Institutional investors purchased a net $9.0 million shares of OPK during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 23.44% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SMITH, GRAHAM & CO. INVESTMENT A... Bought 61.2 Thousand shares of OPKO Health Inc
NORTH STAR INVESTMENT MANAGEMENT... Bought 30.0 Thousand shares of OPKO Health Inc
FOX RUN MANAGEMENT LLC Bought 15.2 Thousand shares of OPKO Health Inc